Canatu delivered second S-100 reactor to major customer in semiconductor sector as expected
Translation: Original published in Finnish on 12/18/2024 at 7:22 am EET.
Canatu announced on Tuesday that it has successfully delivered its second S-100 reactor to a major global semiconductor customer. The news was expected, as the company had already announced in its IPO prospectus that it would deliver the first two reactors this year. The first reactor was delivered to another major customer in September.
The news shows that Canatu's strategy is moving in the right direction as planned, setting the stage for strong growth in the coming years. The ramp-up of the reactor business is central to Canatu's growth, as recurring revenue from royalties and non-discretionary consumables will gradually start to grow as customers use them to manufacture CNT-based EUV pellicle membranes. We have explained the reactor business in more detail in our recent Initiation of coverage report.
Canatu
Canatu is a technology company active in deep technology that creates carbon nanotubes (Canatu CNT), related products and manufacturing equipment for the semiconductor, automotive and medical diagnostics industries. The company operates through two business models, firstly using their own reactors to develop and manufacture CNT products. Second, the company sells its CNT reactors and licenses its related technology, allowing customers to produce the products themselves under a limited license.
Read more on company pageKey Estimate Figures21.10
2023 | 24e | 25e | |
---|---|---|---|
Omsætning | 13,6 | 22,7 | 30,3 |
vækst-% | 62,15 % | 66,83 % | 33,62 % |
EBIT (adj.) | -0,6 | -3,4 | -2,4 |
EBIT-% (adj.) | -4,71 % | -15,08 % | -7,94 % |
EPS (adj.) | -0,04 | -0,09 | -0,04 |
Udbytte | 0,00 | 0,00 | 0,00 |
Udbytte % | |||
P/E (adj.) | - | - | - |
EV/EBITDA | 844,02 | - | - |